In-Silico Identification of the Best Compound Against Leishmania infantum: High Throughput Screening of All FDA Approved Drugs
Objective:Current in-silico research was designed and administered for the screening of 20000 Food and Drug Administration-approved drug compounds with the goal of finding promising drugs against lipophosphoglycan (LPG) and γ-glutamylcysteine synthetase (γ-GCS) of Leishmania infantum.Methods:After t...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2019-12-01
|
Series: | Türkiye Parazitoloji Dergisi |
Subjects: | |
Online Access: |
http://www.turkiyeparazitolderg.org/archives/archive-detail/article-preview/n-silico-dentification-of-the-best-compound-agains/32290
|